For citations:
Orlova R.V., Belyak N.P., Kutukova S.I., Zhukova N.V., Avramenko I.V., Androsova A.V., Zhukova A.E., Ivanova A.K., Popova N.V. Trastuzumab + FOLFOX6/FLOT as perioperative therapy for HER2-positive resectable gastric cancer and cardioesophageal transition: RussTrastPraсtik study (interim analysis). Medical alphabet. 2020;(38):46-51. (In Russ.) https://doi.org/10.33667/2078-5631-2020-38-46-51
Email this article 